Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis
The relative efficacy of different strategies for chronic hepatitis B (CHB) patients with lamivudine resistance (LAM-R) has not yet been systematically studied. Clinical trials were searched in PUBMED, MEDLINE, EMBASE, and CNKI databases up to February 15, 2016. Nine trials including 764 patients me...
Main Authors: | Hui-Lian Wang, Xi Lu, Xudong Yang, Nan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/3435965 |
Similar Items
-
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01) -
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
by: Aoran Luo, et al.
Published: (2019-07-01) -
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
by: Wang Li-Chun, et al.
Published: (2009-10-01) -
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01) -
Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
by: Chao DC, et al.
Published: (2013-08-01)